Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Mammary | 14 | 2016 | 82 | 2.850 |
Why?
|
| Breast Neoplasms | 27 | 2023 | 3110 | 2.170 |
Why?
|
| Artificial Intelligence | 9 | 2023 | 391 | 2.050 |
Why?
|
| Diagnosis, Computer-Assisted | 8 | 2023 | 337 | 1.560 |
Why?
|
| Mammography | 6 | 2023 | 458 | 1.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2016 | 626 | 1.130 |
Why?
|
| Image Enhancement | 7 | 2018 | 505 | 1.070 |
Why?
|
| ROC Curve | 15 | 2018 | 775 | 0.960 |
Why?
|
| Algorithms | 10 | 2023 | 1953 | 0.860 |
Why?
|
| Breast Diseases | 2 | 2018 | 99 | 0.780 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2023 | 461 | 0.770 |
Why?
|
| Pattern Recognition, Automated | 4 | 2010 | 217 | 0.760 |
Why?
|
| Machine Learning | 3 | 2023 | 341 | 0.710 |
Why?
|
| Radiology | 1 | 2023 | 192 | 0.670 |
Why?
|
| Breast | 4 | 2021 | 294 | 0.610 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 3476 | 0.570 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2015 | 165 | 0.550 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 452 | 0.510 |
Why?
|
| Sensitivity and Specificity | 11 | 2018 | 1922 | 0.490 |
Why?
|
| Axilla | 2 | 2014 | 109 | 0.480 |
Why?
|
| Lymph Nodes | 3 | 2015 | 548 | 0.470 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 504 | 0.440 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1448 | 0.420 |
Why?
|
| Radiography | 5 | 2023 | 790 | 0.390 |
Why?
|
| Female | 29 | 2023 | 48696 | 0.320 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 68 | 0.320 |
Why?
|
| Models, Statistical | 3 | 2011 | 585 | 0.290 |
Why?
|
| Linear Models | 1 | 2009 | 413 | 0.280 |
Why?
|
| False Positive Reactions | 4 | 2014 | 212 | 0.280 |
Why?
|
| Humans | 35 | 2023 | 93501 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 1261 | 0.260 |
Why?
|
| User-Computer Interface | 1 | 2008 | 189 | 0.260 |
Why?
|
| Models, Theoretical | 1 | 2009 | 494 | 0.250 |
Why?
|
| Biopsy | 3 | 2018 | 1175 | 0.240 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1546 | 0.240 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 2715 | 0.240 |
Why?
|
| Ultrasonography | 2 | 2013 | 702 | 0.230 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 139 | 0.220 |
Why?
|
| Decision Making | 1 | 2009 | 674 | 0.210 |
Why?
|
| Computers | 1 | 2023 | 102 | 0.200 |
Why?
|
| Densitometry | 1 | 2003 | 23 | 0.200 |
Why?
|
| Patient Care | 1 | 2023 | 97 | 0.190 |
Why?
|
| Genomics | 2 | 2019 | 848 | 0.180 |
Why?
|
| Likelihood Functions | 2 | 2013 | 256 | 0.180 |
Why?
|
| Magnets | 1 | 2021 | 13 | 0.170 |
Why?
|
| Aged | 8 | 2019 | 20430 | 0.170 |
Why?
|
| Area Under Curve | 3 | 2014 | 335 | 0.160 |
Why?
|
| Probability | 2 | 2014 | 355 | 0.160 |
Why?
|
| Retrospective Studies | 8 | 2023 | 10163 | 0.160 |
Why?
|
| Middle Aged | 9 | 2018 | 27569 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 608 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 1713 | 0.150 |
Why?
|
| Prospective Studies | 2 | 2018 | 4559 | 0.130 |
Why?
|
| Computer Simulation | 3 | 2011 | 1118 | 0.130 |
Why?
|
| Tumor Burden | 1 | 2018 | 321 | 0.130 |
Why?
|
| Radiotherapy | 1 | 2018 | 320 | 0.120 |
Why?
|
| Adult | 7 | 2018 | 27918 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1170 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 84 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 7061 | 0.110 |
Why?
|
| Neoplasms | 2 | 2020 | 3169 | 0.100 |
Why?
|
| Observer Variation | 2 | 2013 | 570 | 0.100 |
Why?
|
| Automation | 1 | 2014 | 105 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2364 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1518 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 26 | 0.100 |
Why?
|
| Breast Density | 1 | 2013 | 37 | 0.100 |
Why?
|
| Carcinoma | 1 | 2016 | 439 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 278 | 0.090 |
Why?
|
| Water | 1 | 2014 | 307 | 0.090 |
Why?
|
| Genome, Human | 1 | 2015 | 823 | 0.080 |
Why?
|
| Phenotype | 4 | 2019 | 2544 | 0.080 |
Why?
|
| Documentation | 1 | 2010 | 97 | 0.080 |
Why?
|
| Discriminant Analysis | 1 | 2009 | 64 | 0.080 |
Why?
|
| Prognosis | 2 | 2015 | 3910 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2009 | 217 | 0.070 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2005 | 12 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2006 | 101 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2009 | 402 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 92 | 0.060 |
Why?
|
| Benchmarking | 1 | 2023 | 80 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2002 | 96 | 0.050 |
Why?
|
| Physics | 1 | 2021 | 21 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 136 | 0.040 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 72 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 9606 | 0.040 |
Why?
|
| Software | 1 | 2002 | 670 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 113 | 0.030 |
Why?
|
| United States | 3 | 2020 | 7619 | 0.030 |
Why?
|
| Mass Screening | 1 | 2002 | 696 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 243 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 988 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1996 | 204 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 300 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 572 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1721 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1300 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 482 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1117 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 580 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2017 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2009 | 37 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 302 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 234 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1659 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 4272 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 6930 | 0.010 |
Why?
|
| Parotid Neoplasms | 1 | 1996 | 16 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 1775 | 0.000 |
Why?
|
| Male | 1 | 1996 | 44552 | 0.000 |
Why?
|